Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis

被引：0
|
作者：
L. Karlsson
J. Lundkvist
E. Psachoulia
M. Intorcia
O. Ström
机构：
[1] Quantify Research,Department of Learning, Informatics, Management and Ethics (LIME), Medical Management Centrum (MMC)
[2] Karolinska Institutet,Department of Pharmacy
[3] Uppsala University,undefined
[4] Amgen (Europe) GmbH,undefined
来源：
Osteoporosis International | 2015年 / 26卷
关键词：
Bisphosphonates; Denosumab; Meta-analysis; Persistence; Retrospective; Review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2401 / 2411
页数：10
相关论文
共 50 条
  • [41] DENOSUMAB PERSISTENCE IN POSTMENOPAUSAL AND MALE OSTEOPOROSIS IN ROUTINE CLINICAL PRACTICE IN HUNGARY: A NATIONAL, SINGLE-ARM, PROSPECTIVE OBSERVATIONAL STUDY
    Gaal, J.
    Valkusz, Z.
    Kudlak, K.
    Balogh, I.
    Molnar, E.
    Takacs, I.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S134 - S135
  • [42] Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
    Stuart L. Silverman
    E. Siris
    D. Belazi
    C. Recknor
    A. Papaioannou
    J. P. Brown
    D. T. Gold
    E. M. Lewiecki
    G. Quinn
    A. Balasubramanian
    S. Yue
    B. Stolshek
    D. L. Kendler
    Archives of Osteoporosis, 2018, 13
  • [43] Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
    Silverman, Stuart L.
    Siris, E.
    Belazi, D.
    Recknor, C.
    Papaioannou, A.
    Brown, J. P.
    Gold, D. T.
    Lewiecki, E. M.
    Quinn, G.
    Balasubramanian, A.
    Yue, S.
    Stolshek, B.
    Kendler, D. L.
    ARCHIVES OF OSTEOPOROSIS, 2018, 13 (01)
  • [44] SYSTEMATIC REVIEW AND META-ANALYSIS OF PERSISTENCE WITH ORAL OSTEOPOROSIS THERAPIES IN ROUTINE CLINICAL PRACTICE
    Karlsson, L.
    Hadji, P.
    Silverman, S.
    Cheng, L.
    Intorcia, M.
    Jonsson, E.
    Strom, O.
    Psachoulia, E.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S110 - S111
  • [45] Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
    Miller, P. D.
    Pannacciulli, N.
    Brown, J. P.
    Czerwinski, E.
    Nedergaard, B. S.
    Bolognese, M. A.
    Malouf, J.
    Bone, H. G.
    Reginster, J. -Y.
    Singer, A.
    Wang, C.
    Wagman, R. B.
    Cummings, S. R.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (08): : 3163 - 3170
  • [46] Comparison of Denosumab and Bisphosphonates in Patients With Osteoporosis: A Meta-Analysis of Randomized Controlled Trials
    Lyu, Houchen
    Jundi, Bakr
    Xu, Chang
    Tedeschi, Sara K.
    Yoshida, Kazuki
    Zhao, Sizheng
    Nigwekar, Sagar U.
    Leder, Benjamin Z.
    Solomon, Daniel H.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (05): : 1753 - 1765
  • [47] Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland
    Mary E. Walsh
    Tom Fahey
    Frank Moriarty
    Archives of Osteoporosis, 2021, 16
  • [48] Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland
    Walsh, Mary E.
    Fahey, Tom
    Moriarty, Frank
    ARCHIVES OF OSTEOPOROSIS, 2021, 16 (01)
  • [49] A META-ANALYSIS OF 4 CLINICAL TRIALS OF DENOSUMAB (DMAB) COMPARED WITH BISPHOSPHONATES (BPS) IN POSTMENOPAUSAL WOMEN PREVIOUSLY TREATED WITH ORAL BISPHOSPHONATES (OBPS)
    Miller, P. D.
    Pannacciulli, N.
    Malouf, J.
    Singer, A.
    Czerwinski, E.
    Bone, H. G.
    Wang, C.
    Wagman, R. B.
    Brown, J. P.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S55 - S56
  • [50] TREATMENT PERSISTENCE WITH DENOSUMAB AND ORAL BISPHOSPHONATES (OBPS) IN SWEDISH OSTEOPOROTIC WOMEN OLDER THAN 70 YEARS
    Intorcia, M.
    Karlsson, L.
    Banefelt, J.
    Strom, O.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S435 - S435
12345